Phase 3 trial data shows that ~28.7% average weight reduction is achieved by 68 weeks, with the largest improvements in metabolic markers fasting glucose, A1c, liver fat, blood pressure typically appearing by month 9
Safety-first, evidence-forward guidance for GLP-1s
The cost of Semaglutide GLP-1 treatment with Dr
This is where retatrutide begins to differentiate itself from single and dual agonists
Holding GLP-1RAs before endoscopy may disrupt diabetes management and increase procedure cancellations, yet our findings suggest this practice is justified by the increased, albeit modest, risk of aspiration, especially in upper GI and propofol-assisted procedures, Yeo and colleagues wrote
This lack of oversight raises concerns, since products can contain hidden drugs, banned substances, or incorrect dosages